FOLH1 and neoplasm: Additionally, for individuals undergoing PSMA radionuclide therapy, alterations in PSMA uptake levels can be utilized to assess the treatment’s effectiveness, where a reduction in uptake may indicate a positive treatment response on the tumor (25).